<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="combat infectious diseases through drugs, treatment, and control measures. COVID-19" exact="treatment" post="requires both limiting viral multiplication and neutralizing tissue damage"/>
 <result pre="various steps have been started to safeguard the people, like" exact="social distancing" post="and self-quarantine, which limits our social interactions (4). This"/>
 <result pre="April 21, 2020, the confirmed cases are 10,683, released from" exact="isolation" post="8213, isolated 2233, and deceased 237. The KCDC is"/>
 <result pre="ensure that people are well prepared to conquer this deadly" exact="infection" post="of COVID-19. The government of India has announced the"/>
 <result pre="a cohesive body of knowledge and ensure robust diagnostics and" exact="treatment" post="supply lines in the midst of this pandemic. Hence,"/>
 <result pre="collected and rapid diagnostics methods for accurate results to guide" exact="treatment" post="options. Currently, chloroquine and hydroxychloroquine are the most-used drugs,"/>
 <result pre="or contact with a person who is ill or been" exact="quarantine" post="should approach the government and health-care officials to monitor"/>
 <result pre="can also be collected from the symptomatic patients for the" exact="detection" post="of the viral infection. Oropharyngeal swabs: Another important specimen"/>
 <result pre="specimen recommended by the WHO and CDC to detect SARS-CoV-2" exact="infection" post="is the OP. This swab is collected from the"/>
 <result pre="aspirated fluid with the virus will be collected for the" exact="testing" post="of the COVID-19 infection. Sputum: The patients who have"/>
 <result pre="of COVID-19 infections flying off the charts, accurate and rapid" exact="diagnosis" post="has evolved as a tool to detect and control"/>
 <result pre="IgG antibodies produced by the patient in response to SARS-CoV-2" exact="infection" post="(9). Likewise, ICMR has also issued some guidelines for"/>
 <result pre="(9). Likewise, ICMR has also issued some guidelines for the" exact="diagnosis" post="of COVID-19. The ICMR has recommended the use of"/>
 <result pre="RdRp, S, E, ORF1b, and nsp14, have been targeted for" exact="diagnosis" post="in laboratories worldwide. At this point, it is essential"/>
 <result pre="very early collection, improper handling of the sample, and inaccurate" exact="testing" post="methods. The commonly available RT-PCR tests that are widely"/>
 <result pre="The commonly available RT-PCR tests that are widely used for" exact="detection" post="of COVID-19 take a significant amount of time to"/>
 <result pre="trained personnel and well-equipped laboratories for their use. As rapid" exact="detection" post="tests appear to be a break-through in COVID-19 diagnosis,"/>
 <result pre="recommend the use of RT-PCR as diagnostic tools for the" exact="detection" post="of COVID-19. In addition to these methods, CT scans"/>
 <result pre="addition to these methods, CT scans may aid in the" exact="diagnosis" post="of COVID-19, but this method is not recommended for"/>
 <result pre="for COVID-19, and these tests can be used as preliminary" exact="screening" post="for COVID-19. More research is required to ascertain the"/>
 <result pre="processes increase the levels of procalcitonin in the blood upon" exact="infection" post="or injury. This is concomitant with increased levels of"/>
 <result pre="animal, and clinical studies, the drugs which are advised for" exact="treatment" post="of COVID-19 are Remdesivir, Lopinavir/Ritonavir, Lopinavir/Ritonavir with interferon beta-1a,"/>
 <result pre="chloroquine, and hydroxychloroquine. Remdesivir has been previously tested for Ebola" exact="treatment" post="(15). According to a recent study, an inflammatory drug,"/>
 <result pre="Remidesivir, increases the potential of the drug to reduce viral" exact="infection" post="(16). The Lopinavir/Ritonavir drug is currently provided to treat"/>
 <result pre="in the 1940s, as an aminoquinolone derivative developed for the" exact="treatment" post="of malaria (17). The chemical formula of chloroquine is"/>
 <result pre="idiopathic arthritis. Chloroquine and hydroxychloroquine have been repurposed for the" exact="treatment" post="of several disease conditions, including HIV, Systemic lupus erythematosus,"/>
 <result pre="as an anti-malarial drug and has shown potential in the" exact="treatment" post="of avian influenza A (19). Chloroquine has been indicated"/>
 <result pre="Authorization Information). Chloroquine is currently undergoing clinical trials for the" exact="treatment" post="of COVID-19 (23). CHLOROQUINE/HYDROXYCHLOROQUINE: IS IT PROMISING FOR COVID-19?"/>
 <result pre="24). Chloroquine and its combination of drugs used in the" exact="treatment" post="of COVID-19 has been listed in Table 4. Hydroxychloroquine"/>
 <result pre="functioned at both entries and post-entry stages of the 2019-nCoV" exact="infection" post="in Vero E6 cells. The in vitro study findings"/>
 <result pre="could be used to treat the patients suffering from COVID-19" exact="infection" post="(30). The patients affected with COVID-19 infection and who"/>
 <result pre="suffering from COVID-19 infection (30). The patients affected with COVID-19" exact="infection" post="and who have no complications with the chloroquine drug"/>
 <result pre="1.13 Î¼M at half-maximal concentration against SARS-CoV-2 and blocked viral" exact="infection" post="by increasing the endosomal pH required for viral fusion"/>
 <result pre="(CP) THERAPY SPELLS A HOPE FOR COVID-19 Although a definitive" exact="treatment" post="or specific vaccine for this deadly viral infection is"/>
 <result pre="a definitive treatment or specific vaccine for this deadly viral" exact="infection" post="is still a question to be answered, an experimental"/>
 <result pre="effective during the past epidemics; it could be a potential" exact="treatment" post="option in this current scenario as well. Even the"/>
 <result pre="the virus is still ongoing and the impact of the" exact="infection" post="is still on the rise, despite the various preventive"/>
 <result pre="professional and government officials, which include quarantine, national lockdown, and" exact="social distancing" post="as a measure to control the spread of the"/>
 <result pre="desired specimens to confirm the presence or absence of the" exact="infection" post="in a particular individual. Based on the efficiency of"/>
 <result pre="a therapy to serve the severely affected COVID-19 patients. Home" exact="quarantine" post="should be strictly followed, as it will be easy"/>
 <result pre="load among societies. It is evident that the spread of" exact="infection" post="is mainly through human-to-human transmission; hence it is mandatory"/>
 <result pre="symptom associated with this disease. Containing the spread of SARS-CoV-2" exact="infection" post="will potentially reduce the stress and strain on the"/>
 <result pre="it has emerged as the most intense and petrifying viral" exact="infection" post="to be handled by the human race. Many countries"/>
 <result pre="been initiated to ensure the safety of the people, like" exact="social distancing" post="and self-quarantine, which limits our social interactions. Since the"/>
 <result pre="working rigorously to find the solution to treat the SARS-CoV-2" exact="infection" post="at a rapid pace. Hence, more research is needed"/>
 <result pre="Emerging protective measuresEur Rev Med Pharmaco243422342510.26355/eurrev_202003_2071332271461 5RotheCSchunkMSothmannPet al.2020Transmission of 2019-nCoV" exact="infection" post="from an asymptomatic contact in GermanyN Engl J Med38297097110.1056/NEJMc200146832003551"/>
 <result pre="Disease Prevention and Control (CDC)2020Interim guidelines for collecting, handling, and" exact="testing" post="clinical specimens from persons for coronavirus disease 2019 (COVID-19)https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.htmlaccessed"/>
 <result pre="11collab: World Health Organization (WHO)2020Coronavirus disease (COVID-19) technical guidance: Laboratory" exact="testing" post="for 2019-nCoV in humanshttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical guidance/laboratory-guidanceaccessed on 21 April, 2020"/>
 <result pre="is highly effective in treating avian influenza A H5N1 virus" exact="infection" post="in an animal modelCell Res2330030210.1038/cr.2012.16523208422 20LiCZhuXJiXet al.2017Chloroquine, a FDA-approved"/>
 <result pre="modelCell Res2330030210.1038/cr.2012.16523208422 20LiCZhuXJiXet al.2017Chloroquine, a FDA-approved drug, prevents Zika virus" exact="infection" post="and its associated congenital microcephaly in miceEBioMedicine2418919410.1016/j.ebiom.2017.09.03429033372 21ShiryaevSAMesciPPintoAet al.2017Repurposing"/>
 <result pre="21ShiryaevSAMesciPPintoAet al.2017Repurposing of the anti-malaria drug chloroquine for Zika virus" exact="treatment" post="and prophylaxisSci Rep71577110.1038/s41598-017-15467-629150641 22YaoXYeFZhangMet al.2020In vitro antiviral activity and"/>
 <result pre="and projection of optimized dosing design of hydroxychloroquine for the" exact="treatment" post="of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect"/>
 <result pre="of print]10.1093/cid/ciaa23732150618 23GaoJTianZYangX2020Breakthrough: chloroquine phosphate has shown apparent efficacy in" exact="treatment" post="of COVID-19 associated pneumonia in clinical studiesBiosci Trends14727310.5582/bst.2020.0104732074550 24SavarinoADi"/>
 <result pre="Res3026927110.1038/s41422-020-0282-032020029 27VincentMJBergeronEBenjannetSet al.2005Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J26910.1186/1743-422X-2-6916115318 28DevauxCARolainJMColsonPRaoultD2020New insights on the antiviral effects"/>
 <result pre="Agents[Online ahead of print]10.1016/j.ijantimicag.2020.10594832201353 31GautretPLagierJCParolaPet al.2020Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19: results of an open-label non-randomized clinical trialInt"/>
 <result pre="al.2015The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the" exact="treatment" post="of severe acute respiratory infections of viral etiology: a"/>
 <result pre="systematic review and exploratory meta-analysisJ Infect Dis211809010.1093/infdis/jiu39625030060 36HungIFToKKLeeCKet al.2011Convalescent plasma" exact="treatment" post="reduced mortality in patients with severe pandemic influenza A"/>
 <result pre="for COVID-19Lancet Infect Dis2039840010.1016/S1473-3099(20)30141-932113510 41BobatiSSNaikKR2017Therapeutic plasma exchange - an emerging" exact="treatment" post="modality in patients with neurologic and non-neurologic diseasesJ Clin"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discov61610.1038/s41421-020-0156-032194981 Fig. 1 Collection of Specimens/samples and"/>
 <result pre="as a tool to detect exposure to virus. The rapid" exact="detection" post="kits use blood from a finger prick to detect"/>
 <result pre="Table 1 Details about the specimens/samples used for the COVID-19" exact="detection" post="Specimen Form of sample collection Volume Required Collection Material"/>
 <result pre="0.8-1.4 ml Urine collection container 2-8Â°C To confirm the viral" exact="infection" post="RT-PCR Blood Normal 0.8-1.4 ml EDTA &amp;amp; ACT tubes"/>
 <result pre="ml EDTA &amp;amp; ACT tubes 2-8Â°C To confirm the viral" exact="infection" post="RT-PCR RDT ELISA Neutralization assay Stool Normal - Stool"/>
 <result pre="Stool Normal - Stool container 2-8Â°C To confirm the viral" exact="infection" post="RT-PCR RT-PCR: Reverse Transcription-Polymerase Chain Reaction; RDT: Rapid Diagnostic"/>
 <result pre="for the Management of the COVID-19 Pandemic Thymosin; suramin; conventional" exact="treatment" post="+ adalimumab Not yet recruiting China Severe 2019-nCoV Remdesivir"/>
 <result pre="College HospitalBeijing, Beijing, China The efficacy and safety of carrimycin" exact="treatment" post="in patients with novel coronavirus infectious disease (COVID-19): a"/>
 <result pre="alpha 1b spray in the prevention of novel coronavirus (COVID-19)" exact="infection" post="in highly exposed medical staffs recombinant human interferon alpha"/>
 <result pre="States The efficacy and safety of pirfenidone capsules in the" exact="treatment" post="of severe new coronavirus pneumonia (COVID-19) Pirfenidone - Third"/>
 <result pre="vaccines. Table 3 Details of currently available drugs in the" exact="treatment" post="of COVID-19 Name of Drug Illnesses treated Ribavirin RSV"/>
 <result pre="Table 3 represents the commercially available drugs used for the" exact="treatment" post="of the various forms of coronaviruses. The viral infections"/>
 <result pre="4 Chloroquine and its combination of drugs used in the" exact="treatment" post="of COVID-19 Study Particulars Drugs Dosage Reference Chloroquine (C)"/>
 <result pre="trials Chloroquine phosphate Not specified 15 SARS-CoV-2 and blocked viral" exact="infection" post="by increasing the endosomal pH required for viral fusion"/>
 <result pre="trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection, and" exact="treatment" post="of patients with mild, moderate, and severe COVID-19 Chloroquine"/>
 <result pre="et al., 2020); 43 (Liu et al., 2020) Prescribing Hydroxychloroquine" exact="treatment" post="on a large scale, and decided to perform a"/>
 <result pre="2020) Two drugs, remdesivir and chloroquine phosphate, efficiently inhibited SARS-CoV-2" exact="infection" post="in vitro Remdesivir + chloroquine phosphate Not specified 27"/>
</results>
